| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Dec 18, 2025 | Arcus Biosciences, Inc. | CFO | Sell | 40.0 | -12,662 | -14.53% | ✗ | $278.7K |
| Nov 26, 2025 | Nov 26, 2025 | Arcus Biosciences, Inc. | CFO | Sell | 32.5 | -5,000 | -5.43% | ✓ | $125K |
| Oct 28, 2025 | Oct 29, 2025 | Arcus Biosciences, Inc. | CFO | Sell | 32.5 | -5,000 | -5.15% | ✓ | $100K |
| Dec 31, 2024 | Jan 3, 2025 | Arcus Biosciences, Inc. | CFO | Sell | 32.5 | -3,594 | -5.64% | ✓ | $53.9K |
| Dec 15, 2024 | Dec 17, 2024 | Arcus Biosciences, Inc. | CFO | Sell | 42.5 | -10,099 | -13.68% | ✗ | $162.4K |
| Jan 2, 2024 | Jan 4, 2024 | Arcus Biosciences, Inc. | CFO | Sell | 41.3 | -2,004 | -3.72% | ✓ | $40.1K |
| Dec 18, 2023 | Dec 20, 2023 | Arcus Biosciences, Inc. | CFO | Sell | 42.5 | -5,557 | -9.36% | ✗ | $99.6K |
| Jun 7, 2023 | Jun 9, 2023 | Arcus Biosciences, Inc. | CFO | Sell | 32.5 | -4,049 | -6.38% | ✓ | $81.1K |
| Dec 16, 2022 | Dec 16, 2022 | Arcus Biosciences, Inc. | CFO | Sell | 42.5 | -2,453 | -17.50% | ✗ | $75.4K |
| Dec 16, 2021 | Dec 20, 2021 | Arcus Biosciences, Inc. | CFO | Sell | 46.3 | -1,106 | -13.61% | ✗ | $44.4K |
| Sep 9, 2020 | Sep 9, 2020 | Arcus Biosciences, Inc. | CFO | Buy | 95.0 | +5,000 | 100.00% | ✗ | $107.8K |
| Jun 22, 2020 | Jun 24, 2020 | Unity Biotechnology, Inc. | CFO | Sell | 46.3 | -2,483 | -1.52% | ✗ | $24K |
| Mar 20, 2017 | Mar 21, 2017 | CytomX Therapeutics, Inc. | CFO | Sell | 7.5 | -21,517 | -68.73% | ✓ | $426.3K |